• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: Proton Therapy Breakthrough: Pediatric Cancer Care in Africa & Middle East | Prof. Zaghloul: EPHOC
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > Video > Proton Therapy Breakthrough: Pediatric Cancer Care in Africa & Middle East | Prof. Zaghloul: EPHOC
Video

Proton Therapy Breakthrough: Pediatric Cancer Care in Africa & Middle East | Prof. Zaghloul: EPHOC

ME Desk
ME Desk
Published: August 25, 2025
Share
3 Min Read
SHARE

Professor Muhammad Saad Zaghloul, a leading figure in oncology and Head of Radiation Oncology at the Children Cancer Hospital Egypt (CCHE), at the Seven Emirates Pediatrics Hematology and Oncology Conference in Abu Dhabi. Professor Zaghloul has been instrumental in establishing the first proton beam therapy facility in Africa and the Middle East a true breakthrough in cancer care for children.

Contents
  • The Value of Proton Beam Therapy in Pediatrics
  • A New Era for Low- and Middle-Income Countries

Click here to join our WhatsApp channel here

The Value of Proton Beam Therapy in Pediatrics

Professor Zaghloul emphasized the immense benefit of proton beam therapy for all pediatric cancers. The primary advantage lies in the therapyโ€™s precision, which significantly reduces side effects, especially late effects like secondary malignancies.

  • Precision and Protection: Unlike traditional radiation, proton beams deliver a โ€œprompt and preciseโ€ dose, ensuring the normal surrounding tissues receive minimal to zero radiation.
  • Reduced Late Effects: This protection is vital for children, whose developing bodies are highly susceptible to long-term side effects.
  • Targeting Resistant Tumors: The precision allows doctors to safely increase the radiation dose to highly resistant tumors, such as those at the base of the skull, without harming nearby critical structures like the brain.

A New Era for Low- and Middle-Income Countries

The Professor provided an exciting update on the global expansion of this technology:

  • Global Expansion: The number of proton beam facilities globally has rapidly increased from about 50 in 2017 to 140 today.
  • Access in Developing Nations: Egyptโ€™s facility will be only the fifth in the world among low- and middle-income countries (following China, Russia, India, and Thailand) to offer this cutting-edge treatment.
  • The Egyptian Milestone: The first proton beam therapy facility in Egypt, at the Children Cancer Hospital Egypt (CCHE), is currently in the final stages of installation and is expected to start treating patients in November 2025.
  • Future Hope: While the financial cost remains high, it has decreased dramatically, which, combined with the required technical background and infrastructure, provides hope for further expansion of this vital technology across Africa and the Middle East.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article DOCKTOUR UAEโ€™s Maritime-Medical Venture DOCKTOUR Extends Vital Support to Angola with Donation of Essential Medicinesย 
Next Article KFSHRC KFSHRC Leads Middle East in Epilepsy Surgery with Over 2,000 Successful Procedures

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Proton Therapy Breakthrough: Pediatric Cancer Care in Africa & Middle East | Prof. Zaghloul: EPHOC
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Proton Therapy Breakthrough: Pediatric Cancer Care in Africa & Middle East | Prof. Zaghloul: EPHOC
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?